Physician profile
Anna Magee
NPI 1962466334
$37,427.20
in general payments reported to CMS, 2019-2025
18 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $507 · 2020: $150 · 2021: $9,523 · 2022: $11K · 2023: $9,700 · 2024: $6,120 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Food and Beverage: $881 · Education: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,019.50 |
| Food and Beverage | $881.13 |
| Education | $125.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $20,629.34 | 2019-2022 | |
| Abbvie INC. | $15,579.71 | 2019-2025 | |
| Merz North America, INC. | $489.11 | 2019-2025 | Xeomin |
| Novartis Pharmaceuticals Corporation | $130.54 | 2019-2020 | |
| Galderma Laboratories, L.P. | $114.71 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $99.99 | 2025 | |
| Janssen Biotech, INC. | $79.45 | 2019-2021 | |
| Genzyme Corporation | $70.32 | 2019-2020 | |
| Lilly USA, LLC | $45.39 | 2019 | |
| Hill Dermaceuticals, INC. | $30.73 | 2023 | Tolak |
| Celgene Corporation | $25.64 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $23.58 | 2024 | |
| Almirall LLC | $22.29 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.21 | 2019 | |
| Genentech USA, INC. | $21.03 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $17.31 | 2019 | |
| Dermira, INC. | $12.99 | 2019 | |
| Pfizer INC. | $12.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Magee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.